Related Experiment Videos
Central monoamine dysfunction in diabetes: psychotherapeutic implications: electroanalysis by voltammetry.
1Department of Pharmacology, City University of New York Medical School, NY.
Summary
Diabetes significantly alters dopamine and serotonin release in rat striatum. Acute diabetes increases both neurotransmitters, while chronic diabetes shows impaired release, suggesting a link to mood changes.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- Diabetes mellitus is a metabolic disorder with known neurological complications.
- Neurotransmitter systems, particularly dopaminergic and serotonergic pathways in the striatum, are crucial for motor control and mood regulation.
- Alterations in neurotransmitter release may underlie some of the non-motor symptoms observed in diabetes.
Purpose of the Study:
- To investigate the in vivo effects of streptozotocin-induced diabetes and hyperglycemia on dopamine and serotonin release in the rat striatum.
- To examine the impact of L-tryptophan administration on neurotransmitter release in both diabetic and non-diabetic rats.
- To correlate changes in neurotransmitter availability with potential mood alterations in the diabetic state.
Main Methods:
- In vivo voltammetry was employed to measure dopamine and serotonin release in the striatum of rats.
- Diabetes was induced using streptozotocin (STZ).
- Hyperglycemia was induced, and L-tryptophan was administered to assess its effects on neurotransmitter release.
Main Results:
- Acute diabetes increased striatal dopamine (67%) and serotonin (62%) release.
- Chronic diabetes showed attenuated increases in dopamine (19%) and a return of serotonin release to basal levels.
- L-tryptophan administration decreased dopamine release and increased serotonin release in non-diabetic rats, but decreased both in long-term diabetic rats.
- Hyperglycemia in non-diabetic rats decreased dopamine release (52%) and increased serotonin release (304%).
Conclusions:
- Untreated diabetes is associated with a progressive impairment of striatal dopamine and serotonin release.
- These neurotransmitter dysregulations may contribute to mood disturbances observed in diabetic individuals.
- The findings highlight the complex interplay between metabolic status and central neurotransmission.